Dream Capsules
Natural health product licensed in Canada
- Licence holder
- Yoli, LLC
- NPN or DIN-HM
- 80071090
- Status
- Inactive licence
- Licence date
- 13 July 2016
- Revision date
- 5 July 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 10 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 5 milligramme | Not calculated |
| Valeriana officinalis Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 800 milligramme | 200 milligramme | Not calculated |
| Humulus lupulus Source : Strobiles Extraction ratio : 4:1 Dry plant equivalent : 200 milligramme | 50 milligramme | Not calculated |
| Melissa officinalis Source : Plante | 20 milligramme | Not calculated |
| Biotine | 116 microgrammes | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 1.1 milligramme | Not calculated |
| L-5-hydroxytryptophane Source : Griffonia simplicifolia, graine | 9.8 milligramme | Not calculated |
| Vitamine B6 Source : 5-phosphate de pyridoxal | 5 milligramme | 10,000 µg |
| L-théanine | 30 milligramme | Not calculated |
| Ocimum tenuiflorum Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 2 Grammes | 200 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Extrait de fruit de Vaccinium Vitis-Idaea, Saveur de vanille, Astaxanthine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps to prevent and/or reduce the effects of jet lag (e.g. daytime fatigue, sleep disturbance) for people travelling by plane easterly across two or more time zones. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Sleep aid / (to) help(s) to promote sleep. Help(s) relieve nervousness (calmative/sedative).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consumption with alcohol, other medications or natural health products with sedative properties is not recommended. If you are taking one of the following medications, consult a health care practitioner prior to use: anticoagulant, anticonvulsant, heart or blood pressure medications, immunosuppressive medications, sedative, hypnotic or psychotropic medications, or steroids. If you have one of the following conditions, consult a health care practitioner prior to use: asthma, heart condition, cardiovascular disease, epilepsy, kidney stones, chronic kidney disease, depression and/or related diseases, diabetes or hypoglycaemia, hormonal disorder, immune system disease, liver disease, migraine, or seizure disorders. Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia). Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. Do not use if you have scleroderma. If you are taking antibiotics or nitroglycerin, do not use this product.
- Effets indésirables connus
Mild gastrointestinal symptoms (nausea, vomiting, or cramping) have been known to occur in which case, discontinue use. Hypersensitivity, such as allergy (rare allergic reactions) have been known to occur in which case, discontinue use. Some people may experience drowsiness. Exercise caution if involved in activities requiring mental alertness within 2 hours of consumption. Some people may experience diarrhea, nausea, vomiting and abdominal pain.
Source
Official Health Canada record, licence 80071090
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging